Axogen Inc

AXGNNASDAQ · USD
43.36USD0.00 (-0.07%)
5610

Axogen Inc (AXGN) Covered Calls

As of September 28, 2026, AXGN has 16 covered call opportunities in the coming three months. Return ranges from 6.8 to 61.6% until expiration. Annualized return ranges from 33.8 to 549.0%. The nearest expiration is October 16, 2026. Maximum potential profit is $2,669.

Read more

Running AXGN covered calls helps you generate consistent income from Axogen Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Axogen Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best AXGN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if AXGN stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling AXGN covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Axogen Inc covered call is worth writing.

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments.

Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Income-focused investors, long-term AXGN holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling AXGN covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Axogen Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile75.00% Elevated
  • Market cap (M$)2,544
  • 52 weeks high-18.05%
  • 52 weeks low183.96%
  • Analyst recommendationStrong Buy
    1.27
  • Target price$54.40
    25.46% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E63.12
  • EPS (ttm)-0.67
  • EPS growth next 5 years51.58%

As of September 28, 2026

2026-10-161855.0026.850.102.351174.0027.08549.03-0.23+0.221,3212.25
2026-10-161850.0015.310.352.50699.0016.12326.89-0.81+0.283292.15
2026-11-205355.0026.850.704.001234.0028.46195.99-1.61+0.3093.30
2026-11-205350.0015.313.305.80994.0022.92157.88-7.61+0.4402.50
2026-10-161845.003.781.303.40294.006.78137.49-3.00+0.453562.10
2027-01-1510960.0038.380.153.601679.0038.72129.67-0.35+0.2483.45
2027-04-1620070.0061.440.053.002669.0061.55112.34-0.12+0.1912.95
2026-11-205345.003.785.007.50664.0015.31105.46-11.53+0.55272.50
2027-01-1510955.0026.851.704.301334.0030.77103.02-3.92+0.342512.60
2027-04-1620065.0049.910.504.002214.0051.0693.19-1.15+0.2513.50

As of September 28, 2026

Sell covered calls with the data behind you

Find the best AXGN covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial